05th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200030391 | VIRUS AAV/IGF2, GENETIC TREATMENT METHOD AND USE THEREOF IN PROTEIN MISFOLDING-RELATED DISEASES, SUCH AS HUNTINGTON'S DISEASE | 2020-01-30 |
20200030392 | PHAGE THERAPY | 2020-01-30 |
20200030393 | NUTRITIONAL SUPPLEMENT CONTAINING IRON | 2020-01-30 |
20200030394 | COMPOSITIONS AND METHODS FOR TREATING THE EYE | 2020-01-30 |
20200030395 | PROBIOTICS COMPOSITION CONTAINING HERICIUM ERINACEUS | 2020-01-30 |
20200030396 | COMPOSITION CAPABLE OF PROMOTING TESTOSTERONE SECRETION AND USE THEREOF | 2020-01-30 |
20200030397 | METHOD AND APPARATUS FOR HARVESTING TRICHOMES FROM CANNABIS PLANTS | 2020-01-30 |
20200030398 | SKIN CARE COMPOSITION | 2020-01-30 |
20200030399 | HERBAL COMPOSITIONS OF CALIFORNIA POPPY AND METHOD FOR THE TREATMENT OF SLEEP AND DREAM-RELATED DISORDERS | 2020-01-30 |
20200030400 | ARONIA EXTRACT FOR ENHANCING REACTION TIME AND ATTENTION | 2020-01-30 |
20200030401 | ANTICANCER PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2020-01-30 |
20200030402 | PHARMACEUTICAL COMPOSITIONS HAVING ANTIBACTERIAL, ANTIVIRAL, AND OTHER IMMUNOSTIMULATORY ACTIVITIES | 2020-01-30 |
20200030403 | WOLFBERRY GLYCOPEPTIDE COMPOSITION AND METHODS FOR PREPARING AND USING THE SAME | 2020-01-30 |
20200030404 | COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY | 2020-01-30 |
20200030405 | WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES | 2020-01-30 |
20200030406 | Sincalide Formulations | 2020-01-30 |
20200030407 | Stable Formulations of Linaclotide | 2020-01-30 |
20200030408 | METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 2020-01-30 |
20200030409 | LYPD1 INHIBITOR AND METHOD FOR PRODUCING BIOLOGICAL TISSUE USING SAME | 2020-01-30 |
20200030410 | COMPOSITIONS FOR PROMOTING THE HEALING OF WOUNDS | 2020-01-30 |
20200030411 | Methods and Compositions for Inhibiting Skin Inflammation and Determining Cancer Susceptibility | 2020-01-30 |
20200030412 | IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY | 2020-01-30 |
20200030413 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY CANCER | 2020-01-30 |
20200030414 | THERAPEUTIC AGENT FOR SHORT STATURE | 2020-01-30 |
20200030415 | COMBINATION THERAPY WITH CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES | 2020-01-30 |
20200030416 | SYNTHETIC PLATELETS | 2020-01-30 |
20200030417 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | 2020-01-30 |
20200030418 | ENZYMES AND METHODS FOR CLEAVING N-GLYCANS FROM GLYCOPROTEINS | 2020-01-30 |
20200030419 | MICROORGANISMS AND METHODS FOR PRODUCING BIOLOGICS AND INTRODUCING BIOLOGICS TO SITES | 2020-01-30 |
20200030420 | METHODS OF USING A FIXED DOSE OF A CLOTTING FACTOR | 2020-01-30 |
20200030421 | METHODS FOR INDUCING SELECTIVE APOPTOSIS | 2020-01-30 |
20200030422 | COMBINATION OF VACCINATION AND OX40 AGONISTS | 2020-01-30 |
20200030423 | MATERIALS AND METHODS FOR PRODUCING IMPROVED LENTIVIRAL VECTOR PARTICLES | 2020-01-30 |
20200030424 | HUMANIZED ANTI-CD19 ANTIBODY AND USE THEREOF WITH CHIMERIC ANTIGEN RECEPTOR | 2020-01-30 |
20200030425 | ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF | 2020-01-30 |
20200030426 | TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME | 2020-01-30 |
20200030427 | A MALARIA VACCINE AND METHODS FOR PRODUCING SAME | 2020-01-30 |
20200030428 | VIRULENT AEROMONAS VACCINES AND METHODS | 2020-01-30 |
20200030429 | Immunostimulatory preparation exhibiting antitumor activity | 2020-01-30 |
20200030430 | IMMUNOGENIC COMPOSITIONS | 2020-01-30 |
20200030431 | VACCINES, COMPOSITIONS AND METHODS FOR USE THEREOF TO PREVENT OR REDUCE SEVERITY OF CHOLERA | 2020-01-30 |
20200030432 | ZOONOTIC DISEASE RNA VACCINES | 2020-01-30 |
20200030433 | PEPTIDE DISPLAYING BACTERIOPHAGE NANOPARTICLES AND RELATED COMPOSITIONS AND METHODS | 2020-01-30 |
20200030434 | SYSTEM AND METHOD | 2020-01-30 |
20200030435 | CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS | 2020-01-30 |
20200030436 | MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE | 2020-01-30 |
20200030437 | COMPOSITIONS AND METHODS FOR INDUCING PROTECTIVE IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION | 2020-01-30 |
20200030438 | VACCINE AGAINST PORCINE PARVOVIRUS | 2020-01-30 |
20200030439 | Mixtures of Polysaccharide-Protein Pegylated Compounds | 2020-01-30 |
20200030440 | Financial Method | 2020-01-30 |
20200030441 | Lipidated Immune Response Modifier Compound Compositions, Formulations, and Methods | 2020-01-30 |
20200030442 | COMBINATION THERAPIES | 2020-01-30 |
20200030443 | METHODS OF TREATING LUNG CANCER WITH A PD-1 AXIS BINDING ANTAGONIST, A PLATINUM AGENT, AND A TOPOISOMERASE II INHIBITOR | 2020-01-30 |
20200030444 | SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION | 2020-01-30 |
20200030445 | STABLE FORMULATIONS OF HUMANIZED ANTI-TAU ANTIBODY | 2020-01-30 |
20200030446 | ENGINEERED LIGHT-ACTIVATED ANION CHANNEL PROTEINS AND METHODS OF USE THEREOF | 2020-01-30 |
20200030447 | Therapeutic Treatment | 2020-01-30 |
20200030448 | COMPOSITIONS COMPRISING FUSIDIC ACID AND PACKAGES THEREFOR | 2020-01-30 |
20200030449 | LIQUID COMPOSITION CONTAINING PRADOFLOXACIN | 2020-01-30 |
20200030450 | COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION | 2020-01-30 |
20200030451 | POLYMER-SEMAXANIB MOIETY CONJUGATES | 2020-01-30 |
20200030452 | Process for the Manufacture of a Tumor-Vasculature Targeting Antitumor Agent | 2020-01-30 |
20200030453 | METHOD FOR PREPARING ANTIBODY-DRUG CONJUGATE | 2020-01-30 |
20200030454 | ROR1 Antibody Immunoconjugates | 2020-01-30 |
20200030455 | MULTISTEP TUMOR TARGETING BY TAGGED ANTIBODY DERIVATIVES AND TAGGED DRUGS | 2020-01-30 |
20200030456 | QUINONE-CONTAINING CONJUGATES | 2020-01-30 |
20200030457 | DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY | 2020-01-30 |
20200030458 | Gene Therapy for the Treatment of CNGB1-linked Retinitis Pigmentosa | 2020-01-30 |
20200030459 | TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN | 2020-01-30 |
20200030460 | RNA Containing Modified Nucleosides and Methods of Use Thereof | 2020-01-30 |
20200030461 | Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes and Prostate Specific Membrane Antigen Ligands | 2020-01-30 |
20200030462 | GREEN SYNTHESIS OF BIOCOMPATIBLE AND NEAR INFRARED ACTIVE EUGENATE (4-allyl-2-methoxyphenolate) CAPPED IRON OXIDE NANOPARTICLES FOR DEEP TISSUE IMAGING AND THERAPY | 2020-01-30 |
20200030463 | USE RADIUM RA-223 DICHLORIDE FOR THE TREATMENT OF MULTIPLE MYELOMA | 2020-01-30 |
20200030464 | Stable, concentrated radionuclide complex solutions | 2020-01-30 |
20200030465 | Stable, concentrated radionuclide complex solutions | 2020-01-30 |
20200030466 | Stable, concentrated radionuclide complex solutions | 2020-01-30 |
20200030467 | Stable, concentrated radionuclide complex solutions | 2020-01-30 |
20200030468 | Cellular Targeted Label Delivery System | 2020-01-30 |
20200030469 | METHOD AND APPARATUS FOR STERILIZING AND DISINFECTING AIR AND SURFACES AND PROTECTING A ZONE FROM EXTERNAL MICROBIAL CONTAMINATION | 2020-01-30 |
20200030470 | MOBILE STERILIZATION APPARATUS AND METHOD FOR USING THE SAME | 2020-01-30 |
20200030471 | STEAM CABINET | 2020-01-30 |
20200030472 | Bidet Having Bidet Seat Sterilizing Function | 2020-01-30 |
20200030473 | LIGHT INTRODUCTION DEVICE AND STERILIZATION SYSTEM | 2020-01-30 |
20200030474 | ANTI-ODOR COMPOSITIONS, STRUCTURES HAVING ANTI-ODOR CHARACTERISTICS, METHODS OF MAKING THE ANTI-ODOR COMPOSITIONS AND THE STRUCTURES | 2020-01-30 |
20200030475 | SYSTEM AND METHOD FOR DISINFECTING A SURFACE OF AN OBJECT WITH IODINE-LADEN GAS | 2020-01-30 |
20200030476 | STERILIZATION SYSTEM WITH INTEGRATED INSTRUMENT RECALL CAPABILITIES AND RELATED METHODS | 2020-01-30 |
20200030477 | SYSTEMS, DEVICES, AND METHODS INCLUDING IMPLANTABLE DEVICES WITH ANTI-MICROBIAL PROPERTIES | 2020-01-30 |
20200030478 | AIR PURIFIER | 2020-01-30 |
20200030479 | MATERIALS THAT SHRINK IN ONE DIMENSION AND EXPAND IN ANOTHER DIMENSION | 2020-01-30 |
20200030480 | PAD FOR ALLEVIATING AND TREATING PLASMA PROTEIN EXUDATION SKIN DISEASES INCLUDING ATOPIC DISEASES | 2020-01-30 |
20200030481 | HEMOSTATIC SPONGE | 2020-01-30 |
20200030482 | WATER ABSORBENT RESIN COMPOSITION, ABSORBENT, AND ABSORBENT ARTICLE | 2020-01-30 |
20200030483 | SOFT TISSUE ADHESIVE COMPOSITION OF ALPHA-TCP AND PHOSPHORYLATED AMINO ACID | 2020-01-30 |
20200030484 | COMPOSITION FOR HARD TISSUE REPAIR AND KIT FOR HARD TISSUE REPAIR | 2020-01-30 |
20200030485 | COMPOSITION FOR HARD TISSUE REPAIR AND KIT FOR HARD TISSUE REPAIR | 2020-01-30 |
20200030486 | METHODS OF MAKING FIBRIN COMPOSITIONS AND ARTICLES | 2020-01-30 |
20200030487 | METHOD FOR PRODUCING ANTIBACTERIAL BIOLOGICAL IMPLANT | 2020-01-30 |
20200030488 | PROCESSES FOR COATING INORGANIC PARTICLES WITH A PEPTIDE OR PROTEIN USEFUL FOR IMPROVING CELLULAR ACTIVITY RELATED TO BONE GROWTH | 2020-01-30 |
20200030489 | ONE-STEP FORMED GEL FIBER COMPOSITE SCAFFOLD MATERIAL AND PREPARATION METHOD AND USE THEREOF | 2020-01-30 |
20200030490 | HYALURONIC ACID-COLLAGEN MATRICES FOR DERMAL FILLING AND VOLUMIZING APPLICATIONS | 2020-01-30 |